definition of immunity
immunity: resistance to a specific disease
definition of antigen
antigen: “substance” that induces the immune response, e.g., bacteria, viruses
definition of antibody
antibody:“products” of immune response; globulin type of protein
Immunoglobulin
immunoglobulin: – an antibody, immune globulin, Ig
IgM:
first antibody produced in immune response
indicates current or recent infection or exposure to antigen
IgG:
second antibody produced in the immune response
indicates past infection (when IgM absent)
Antigenic stimulation of B cells (lymphocytes) yields:
clone of antibody–producing cells (plasma cells)
clone of memory cells (ready to jump into action if the same antigen comes along again)
Immune response after primary immunization
no detectable antibodies for a week or longer
a small burst of IgM antibodies occurs first
a small burst of IgG antibodies follows
Immune response after second, third, and booster shots:
almost immediate response due to activation of memory cells
a small burst of IgM
a large burst of IgG provides protective levels of antibody
Clinical case VS Sub-Clinical Case
A person may have a CLINICAL case of a disease (have symptoms) or may have a SUB –CLINCIAL case (no symptoms). In both instances the person will make IgM antibodies first and then IgG specific antibodies that can be detected by a blood test – will tell if a recent or past exposure.
What is TITER?
The amount of antibody present is expressed as its TITER (i.e. how much antibody is present). For example, you may have had a Rubella titer performed. If the results indicate that you have no immunity (you never had the disease or an effective immunization), or that the titer is too low to be protective, you will be requested to have an immunization.
Factors Affecting Response to Immunization
Products Used for Immunization
Types of Immunity
Routine Immunization Schedule
Nothing until 2 months old
-diptheria, pertussis, tetanus (DPT)
-polio
-Haemophilus influenzae type B (Hib) – can cause meningitis
-MMR – , measles (rubeola/red measles), mumps, rubella (german measles)
-Chicken pox (Varicella)
-Meningococcal conjugate (for some types of Neisseria meningitis)
-Pneumococcal conjugate (for some types of Streptococcus pneumoniae)
-hepatitis B
-yearly influenzae
-Booster shots: diphtheria and tetanus every ten years
Rubella Immunization
Immunization against Hepatitis B
Immune Status to Chicken Pox
Why tuberculosis is currently a serious problem
-increase in the number of people infected and diseased
-emergence of drug–resistant strains
How is tuberculosis spread
-direct contact with respiratory secretions
-droplet nuclei: greatest danger because they remain suspended in the air, the bacteria remain viable for a long time, and the particles are too small to be trapped by cilia lining the respiratory tract
Usual sequence of events following inhalation of tubercle bacilli:
-bacteria multiply slowly in the lung for 3 – 6 weeks
-cellular immune system becomes activated during this time
-spread of bacteria halted – walled off by a group cells – called a granulonmata
person is infected but does not get disease and is not contagious
Incidence of Tuberculosis
-only about 5% of those infected develop TB
-another 5–10% of those infected may develop disease later in life when the immune system breaks down; dormant bacteria are reactivated
Symptoms of Tuberculosis
initially vague … persistent cough; fever of unknown origin
later … bloody sputum, organ dysfunction as other organs infected
Tuberculin skin test:
-intradermal injection in forearm of solution containing tubercle protein
-read in 48 hours for raised, hard area
-this is not a vaccine
Reasons for positive tuberculin skin test:
Your body has seen tubercular protein “sometime, somehow, somewhere”
-person currently has tuberculosis
-person had tuberculosis in past
-person inhaled bacteria; infected but no disease (5% may develop disease later in life)
-person has been immunized against tuberculosis (BCG vaccine)
When tuberculin testing is done:
at start of employment in health care
on a regular basis following the initial testing
following a known exposure